Evidence map›Paper›PMID 26860334›Full record

ArticleSubstance abuse2016

Community correctional agents' views of medication-assisted treatment: Examining their influence on treatment referrals and community supervision practices.

Shannon Gwin Mitchell, Jennifer Willet, Laura B Monico, Amy James, Danielle S Rudes, Jill Viglione, Robert P Schwartz, Michael S Gordon, Peter D Friedmann

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Substance abuse, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
9.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 78 citations in OpenAlex.

  1. Pharmacotherapy for opioid addiction in community corrections.International review of psychiatry (Abingdon, England) · 2018
    Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. An Exploration of Practitioners' Perceptions and Beliefs About Trauma-Informed Youth Drug Prevention Programs: a Qualitative Study.Prevention science : the official journal of the Society for Prevention Research · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Shannon Gwin Mitchella Friends Research Institute, Inc. , Baltimore , Maryland , USA.
Jennifer Willetb School of Social Work , University of Connecticut , West Hartford , Connecticut , USA.
Laura B Monicoa Friends Research Institute, Inc. , Baltimore , Maryland , USA.
Amy Jamesb School of Social Work , University of Connecticut , West Hartford , Connecticut , USA.
Danielle S Rudesc Center for Advancing Correctional Excellence , George Mason University , Fairfax , Virginia , USA.
Jill Viglioned University of Texas at San Antonio , San Antonio , Texsa , USA.
Robert P Schwartza Friends Research Institute, Inc. , Baltimore , Maryland , USA.
Michael S Gordona Friends Research Institute, Inc. , Baltimore , Maryland , USA.
Peter D Friedmanne Veteran Affairs Medical Center , Providence , Rhode Island , USA.
Friends Research Institute · USUniversity of Hartford · USGeorge Mason University · USThe University of Texas at San Antonio · USVeterans Health Administration · US

Funding

Implementing Effective HIV/Drug Treatment in Corrections-MidStates CJ-DATS CenterU01DA016230 · NIDA · UNIVERSITY OF DELAWARE · PI VISHER, CHRISTINE A · 2002 to 2013
$7.5M
Implementing and Sustaining Innovations in Criminal Justice-DATS 2 (TCU RC)U01DA016190 · NIDA · TEXAS CHRISTIAN UNIVERSITY · PI KNIGHT, KEVIN · 2002 to 2012
$6.9M
Continuum of Care for Drug-Involved OffendersU01DA016191 · NIDA · RHODE ISLAND HOSPITAL (PROVIDENCE, RI) · PI FRIEDMANN, PETER D, STEIN, LYNDA A · 2002 to 2013
$6.7M
The Pacific Coast Research Center of the NIDA CJ-DATSU01DA016211 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI PRENDERGAST, MICHAEL LAURENT · 2002 to 2013
$6.4M
CT Research Center for Criminal Justice Drug Abuse Treatment Study CenterU01DA016194 · NIDA · UNIVERSITY OF CONNECTICUT STORRS · PI FRISMAN, LINDA K · 2002 to 2012
$6.4M
Central States Criminal Justice Drug Abuse CenterU01DA016205 · NIDA · UNIVERSITY OF KENTUCKY · PI LEUKEFELD, CARL G · 2002 to 2012
$6.1M
Health Services Research: Extended Release Naltrexone for Opioid-Dependent YouthR01DA033391 · NIDA · FRIENDS RESEARCH INSTITUTE, INC. · PI MITCHELL, SHANNON GWIN · 2013 to 2018
$3.3M
The Pennsylvania Research Center at Temple UniversityU01DA025284 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI BELENKO, STEVEN R · 2009 to 2013
$2.8M
The Arizona Network for the Study of Implementation EffectivenessU01DA025307 · NIDA · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI SHAFER, MICHAEL S · 2008 to 2012
$2.8M
SBIRT Implementation for Adolescents in Urban Federally Qualified Health CentersR01DA034258 · NIDA · FRIENDS RESEARCH INSTITUTE, INC. · PI MITCHELL, SHANNON GWIN · 2012 to 2015
$2.0M
Implementing Treatment Initiatives for Criminal Justice ClientsU01DA025233 · NIDA · FRIENDS RESEARCH INSTITUTE, INC. · PI KINLOCK, TIMOTHY W · 2009 to 2010
$977k
NIDA NIH HHS 5R01DA033391-03NIDA NIH HHS 5R01DA034258-04NIDA NIH HHS R01 DA033391NIDA NIH HHS R01 DA034258NIDA NIH HHS U01 DA016190NIDA NIH HHS U01DA016190NIDA NIH HHS U01 DA016191NIDA NIH HHS U01DA016191NIDA NIH HHS U01 DA016194NIDA NIH HHS U01DA016194NIDA NIH HHS U01 DA016205NIDA NIH HHS U01DA016205NIDA NIH HHS U01 DA016211NIDA NIH HHS U01DA016211NIDA NIH HHS U01 DA016230NIDA NIH HHS U01DA016230NIDA NIH HHS U01 DA025233NIDA NIH HHS U01DA025233NIDA NIH HHS U01 DA025284NIDA NIH HHS U01DA025284NIDA NIH HHS U01 DA025307NIDA NIH HHS U01DA025307
6 · The paper itself

Abstract

backgroundAlcohol and opioid use disorders are common among adults under community supervision. Although several medications (medication-assisted treatment or MAT) are Food and Drug Administration (FDA)-approved to treat such disorders, they are underutilized with this population despite established effectiveness at decreasing substance use. This paper examines how community correctional agents' understanding of addiction and views of MAT influence their professional actions regarding addiction medications.

methodsA total of 118 semistructured qualitative interviews were conducted with community correctional agents taking part in the CJ-DATS MATICCE implementation study across 20 parole/probation offices in 9 US states. Using grounded theory methodology and an iterative analytic approach, issues of role perception, views of MAT, current treatment referral, and community supervision practices were explored.

resultsAgents often had limited autonomy to make direct treatment referrals, regardless of their views of MAT, as they were required to follow court orders and their organization's policies and procedures. Within some organizations, community correctional agents held sufficient autonomy to make direct treatment referrals, with agents struggling to reconcile their desire to support their clients who needed MAT with concerns about the abuse potential of opioid agonist medications. Viewing MAT as a "treatment of last resort" was counterbalanced by the view that it was an effective evidence-based practice. Agents described how MAT impacted their ability to supervise clients and how their knowledge and understanding of MAT was directly influenced by watching their clients who were successful or unsuccessful on MAT. Even those agents who were more accepting of MAT were largely unsupportive of it long-term use.

conclusionsCommunity correctional agents' views of MAT were influenced by their understanding of addiction as well as their experiences supervising clients receiving treatment with medications, but whether or not MAT referrals were made was not always within their control.

Indexed as

Health Knowledge, Attitudes, PracticeCommunity Health ServicesFemaleHumansMaleMethadoneMiddle AgedOpiate Substitution TreatmentOpioid-Related DisordersPoliceQualitative ResearchReferral and ConsultationUnited StatesMethadoneBuprenoprhineimplementationmedication-assisted treatmentmethadoneparoleprobation

Identifiers

PMID26860334
PMCPMC4823810
OpenAlexW2298351724

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.